Literature DB >> 15872202

Detection of acute infections during HIV testing in North Carolina.

Christopher D Pilcher1, Susan A Fiscus, Trang Q Nguyen, Evelyn Foust, Leslie Wolf, Del Williams, Rhonda Ashby, Judy Owen O'Dowd, J Todd McPherson, Brandt Stalzer, Lisa Hightow, William C Miller, Joseph J Eron, Myron S Cohen, Peter A Leone.   

Abstract

BACKGROUND: North Carolina has added nucleic acid amplification testing for the human immunodeficiency virus (HIV) to standard HIV antibody tests to detect persons with acute HIV infection who are viremic but antibody-negative.
METHODS: To determine the effect of nucleic acid amplification testing on the yield and accuracy of HIV detection in public health practice, we conducted a 12-month observational study of methods for state-funded HIV testing. We compared the diagnostic performance of standard HIV antibody tests (i.e., enzyme immunoassay and Western blot analysis) with an algorithm whereby serum samples that yielded negative results on standard antibody tests were tested again with the use of nucleic acid amplification. A surveillance algorithm with repeated sensitive-less-sensitive enzyme immunoassay tests was also evaluated. HIV infection was defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroconversion.
RESULTS: Between November 1, 2002, and October 31, 2003, 109,250 persons at risk for HIV infection who had consented to HIV testing presented at state-funded sites. There were 606 HIV-positive results. Established infection, as identified by standard enzyme immunoassay or Western blot analysis, appeared in 583 participants; of these, 107 were identified, with the use of sensitive-less-sensitive enzyme immunoassay tests, as recent infections. A total of 23 acutely infected persons were identified only with the use of the nucleic acid amplification algorithm. With all detectable infections taken into account, the sensitivity of standard antibody testing was 0.962 (95 percent confidence interval, 0.944 to 0.976). There were two false positive results on nucleic acid amplification tests. The specificity and positive predictive value of the algorithm that included nucleic acid amplification testing were greater than 0.999 (95 percent confidence interval, 0.999 to >0.999) and 0.997 (95 percent confidence interval, 0.988 to >0.999), respectively. Of the 23 acute HIV infections, 16 were detected at sexually transmitted disease clinics. Emergency measures for HIV prevention protected 48 sex partners and one fetus from high-risk exposure to HIV.
CONCLUSIONS: The addition of nucleic acid amplification testing to an HIV testing algorithm significantly increases the identification of cases of infection without impairing the performance of diagnostic testing. The detection of highly contagious, acutely infected persons creates new opportunities for HIV surveillance and prevention. Copyright 2005 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872202     DOI: 10.1056/NEJMoa042291

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  162 in total

1.  Evaluation of pooled rapid HIV antibody screening of patients admitted to a San Diego Hospital.

Authors:  Sanjay R Mehta; Vu T Nguyen; Georgina Osorio; Susan Little; Davey M Smith
Journal:  J Virol Methods       Date:  2011-04-12       Impact factor: 2.014

2.  Integrating acute HIV infection within routine public health surveillance practices in New York City.

Authors:  Sara Bodach; Sarah Braunstein; Marie Antoinette Bernard; Charulata Jain Sabharwal; Adey Tsega; Colin Shepard
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

3.  Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools.

Authors:  Steven F Ethridge; Clyde Hart; Debra L Hanson; Monica M Parker; Timothy J Sullivan; Berry Bennett; Petrice Stephens; Joslyn Hilliard; Pragna Patel
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples?

Authors:  Natasha Gous; Lesley Scott; Olga Perovic; Francios Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

5.  binGroup: A Package for Group Testing.

Authors:  Christopher R Bilder; Boan Zhang; Frank Schaarschmidt; Joshua M Tebbs
Journal:  R J       Date:  2010-12-01       Impact factor: 3.984

6.  Antiretroviral therapy as HIV prevention: status and prospects.

Authors:  Kenneth H Mayer; Kartik K Venkatesh
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

7.  Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

Authors:  Cynthia L Gay; Sarah J Willis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Joe Sebastian; Amanda M Crooks; Mehri S McKellar; David M Margolis; Susan A Fiscus; Charles B Hicks; Guido Ferrari; Joseph J Eron
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

8.  No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience.

Authors:  Joanne D Stekler; Kenneth Tapia; Janine Maenza; Claire E Stevens; George A Ure; Joshua D O'Neal; Aric Lane; James I Mullins; Robert W Coombs; Sarah Holte; Ann C Collier
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-13       Impact factor: 2.205

9.  Use of the Bio-Rad Geenius HIV-1/2 supplemental assay for the testing of oral fluids for the presence of HIV antibody.

Authors:  Maria Elma; Kathryn Krusel; Megan Crumpler; Nico Tavella; Ali Talan; Jonathon Rendina; Mark Pandori
Journal:  J Clin Virol       Date:  2020-05-06       Impact factor: 3.168

Review 10.  Developments in CD4 and viral load monitoring in resource-limited settings.

Authors:  Christopher F Rowley
Journal:  Clin Infect Dis       Date:  2013-11-11       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.